Crimson Publishers Publish With Us Reprints e-Books Video articles

Abstract

Novel Approaches in Cancer Study

Limitations of Immunotherapeutic Approaches for Cancer Treatment

  • Open or CloseDaniel Amsterdam1* and Barbara E Ostrov2

    1Emeritus Professor, Departments of Microbiology, Immunology, Pathology and Medicine, Jacobs School of Medicine and Biomedical Sciences, USA

    2Endowed Professor and Chair, Department of Pediatrics, Albany Medical College, USA

    *Corresponding author:Daniel Amsterdam, Emeritus Professor, Departments of Microbiology, Immunology, Pathology and Medicine, Buffalo, New York, USA

Submission: May 20, 2019 Published: June 11, 2019

DOI: 10.31031/NACS.2019.02.000549

ISSN:2637-773X
Volume2 Issue5

Abstract

Of the multiple approaches to cancer therapy, few are as complex as those regimens that encompass immune-based agents. Immunotherapeutic approaches have been the central focus of medical investigators for the past several years. This advance in oncologic care is highlighted by the recognition of the Nobel commission in awarding the 2018 Nobel prize to Allison and Honjo [1].

Get access to the full text of this article